ARTICLES BY MICHAEL BLACKTON
- 
                
            Contingency Planning For Quality In The Cell And Gene Sector Due To COVID-1912/7/2020Maintaining clinical trials during the COVID-19 pandemic has presented quite a challenge for those companies exploring novel therapies. 
- 
                
            COVID-19's Impact On Patient Centricity4/20/2020Michael Blackton, VP QA CMC and John Lunger Chief Patient Supply Officer at Adaptimmune cover COVID-19's impact on patient centricity. 
- 
                
            Changes To Anticipate In A Post-COVID Climate4/13/2020In this brief video, Michael Blackton, VP QA CMC and John Lunger Chief Patient Supply Officer at Adaptimmune discuss changes to anticipate in the post-COVID climate. 
 
                 
 
                         
                        